Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 157, 258-265
Abstract
No abstract availableKeywords
Funding Information
- Spanish Ministry of Economy and Competitiveness (SAF2007/61862, SAF2011-25020, SAF2015-67457-R)
This publication has 51 references indexed in Scilit:
- Changes in the Brain Endocannabinoid System in Rat Models of DepressionNeurotoxicity Research, 2017
- Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatmentPsychopharmacology, 2013
- The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brainBiochemical Pharmacology, 2012
- Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contentsJournal of Neural Transmission, 2008
- Decreased depression in marijuana usersAddictive Behaviors, 2006
- Brain Serotonin2 Receptors in Major DepressionArchives of General Psychiatry, 2000
- Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victimsBrain Research, 1995
- Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victimsBrain Research, 1994
- Modulation of ion-channel function by G-protein-coupled receptorsTrends in Neurosciences, 1994
- Heterogeneity of three electrophoretically distinct Go α‐subunits in mammalian brainFEBS Letters, 1992